In-context learning (ICL) is emerging as a promising technique for achieving universal medical image segmentation, where a variety of objects of interest across imaging modalities can be segmented using a single model. Nevertheless, its performance is highly sensitive to the alignment between the query image and in-context image-mask pairs. In a clinical scenario, the scarcity of annotated medical images makes it challenging to select optimal in-context pairs, and fine-tuning foundation ICL models on contextual data is infeasible due to computational costs and the risk of catastrophic forgetting. To address this challenge, we propose Cycle Context Verification (CCV), a novel framework that enhances ICL-based medical image segmentation by enabling self-verification of predictions and accordingly enhancing contextual alignment. Specifically, CCV employs a cyclic pipeline in which the model initially generates a segmentation mask for the query image. Subsequently, the roles of the query and an in-context pair are swapped, allowing the model to validate its prediction by predicting the mask of the original in-context image. The accuracy of this secondary prediction serves as an implicit measure of the initial query segmentation. A query-specific prompt is introduced to alter the query image and updated to improve the measure, thereby enhancing the alignment between the query and in-context pairs. We evaluated CCV on seven medical image segmentation datasets using two ICL foundation models, demonstrating its superiority over existing methods. Our results highlight CCV's ability to enhance ICL-based segmentation, making it a robust solution for universal medical image segmentation. The code will be available at https://github.com/ShishuaiHu/CCV.

Neurodegeneration and cognitive impairment are commonly reported in Alzheimers disease (AD); however, their multivariate links are not well understood. To map the multivariate relationships between whole brain neurodegenerative (WBN) markers, global cognition, and clinical severity in the AD continuum, we developed the explainable artificial intelligence (AI) methods, validated on semi-simulated data, and applied the outperforming method systematically to large-scale experimental data (N=1,756). The outperforming explainable AI method showed robust performance in predicting cognition from regional WBN markers and identified the ground-truth simulated dominant brain regions contributing to cognition. This method also showed excellent performance on experimental data and identified several prominent WBN regions hierarchically and simultaneously associated with cognitive declines across the AD continuum. These multivariate regional features also correlated with clinical severity, suggesting their clinical relevance. Overall, this study innovatively mapped the multivariate regional WBN-cognitive-clinical severity relationships in the AD continuum, thereby significantly advancing AD-relevant neurobiological pathways.

Echocardiography traditionally requires experienced operators to select and interpret clips from specific viewing angles. Clinical decision-making is therefore limited for handheld cardiac ultrasound (HCU), which is often collected by novice users. In this study, we developed a view-agnostic deep learning framework to estimate left ventricular ejection fraction (LVEF), patient age, and patient sex from any of several views containing the left ventricle. Model performance was: (1) consistently strong across retrospective transthoracic echocardiography (TTE) datasets; (2) comparable between prospective HCU versus TTE (625 patients; LVEF r2 0.80 vs. 0.86, LVEF [> or [≤]40%] AUC 0.981 vs. 0.993, age r2 0.85 vs. 0.87, sex classification AUC 0.985 vs. 0.996); (3) comparable between prospective HCU data collected by experts versus novice users (100 patients; LVEF r2 0.78 vs. 0.66, LVEF AUC 0.982 vs. 0.966). This approach may broaden the clinical utility of echocardiography by lessening the need for user expertise in image acquisition.

Introduction: Chest CT scans are increasingly used in dyspneic patients where acute heart failure (AHF) is a key differential diagnosis. Interpretation remains challenging and radiology reports are frequently delayed due to a radiologist shortage, although flagging such information for emergency physicians would have therapeutic implication. Artificial intelligence (AI) can be a complementary tool to enhance the diagnostic precision. We aim to develop an explainable AI model to detect radiological signs of AHF in chest CT with an accuracy comparable to thoracic radiologists. Methods: A single-center, retrospective study during 2016-2021 at Copenhagen University Hospital - Bispebjerg and Frederiksberg, Denmark. A Boosted Trees model was trained to predict AHF based on measurements of segmented cardiac and pulmonary structures from acute thoracic CT scans. Diagnostic labels for training and testing were extracted from radiology reports. Structures were segmented with TotalSegmentator. Shapley Additive explanations values were used to explain the impact of each measurement on the final prediction. Results: Of the 4,672 subjects, 49% were female. The final model incorporated twelve key features of AHF and achieved an area under the ROC of 0.87 on the independent test set. Expert radiologist review of model misclassifications found that 24 out of 64 (38%) false positives and 24 out of 61 (39%) false negatives were actually correct model predictions, with the errors originating from inaccuracies in the initial radiology reports. Conclusion: We developed an explainable AI model with strong discriminatory performance, comparable to thoracic radiologists. The AI model's stepwise, transparent predictions may support decision-making.

BackgroundPositron Emission Tomography (PET) myocardial perfusion imaging (MPI) is a powerful tool for predicting coronary artery disease (CAD). Coronary artery calcium (CAC) provides incremental risk stratification to PET-MPI and enhances diagnostic accuracy. We assessed additive value of CAC score, derived from PET/CT attenuation maps to stress TPD results using the novel 18F-flurpiridaz tracer in detecting significant CAD. Methods and ResultsPatients from 18F-flurpiridaz phase III clinical trial who underwent PET/CT MPI with 18F-flurpiridaz tracer, had available CT attenuation correction (CTAC) scans for CAC scoring, and underwent invasive coronary angiography (ICA) within a 6-month period between 2011 and 2013, were included. Total perfusion deficit (TPD) was quantified automatically, and CAC scores from CTAC scans were assessed using artificial intelligence (AI)-derived segmentation and manual scoring. Obstructive CAD was defined as [≥]50% stenosis in Left Main (LM) artery, or 70% or more stenosis in any of the other major epicardial vessels. Prediction performance for CAD was assessed by comparing the area under receiver operating characteristic curve (AUC) for stress TPD alone and in combination with CAC score. Among 498 patients (72% males, median age 63 years) 30.1% had CAD. Incorporating CAC score resulted in a greater AUC: manual scoring (AUC=0.87, 95% Confidence Interval [CI] 0.34-0.90; p=0.015) and AI-based scoring (AUC=0.88, 95%CI 0.85-0.90; p=0.002) compared to stress TPD alone (AUC 0.84, 95% CI 0.80-0.92). ConclusionsCombining automatically derived TPD and CAC score enhances 18F-flurpiridaz PET MPI accuracy in detecting significant CAD, offering a method that can be routinely used with PET/CT scanners without additional scanning or technologist time. CONDENSED ABSTRACTO_ST_ABSBackgroundC_ST_ABSWe assessed the added value of CAC score from hybrid PET/CT CTAC scans combined with stress TPD for detecting significant CAD using novel 18F-flurpiridaz tracer Methods and resultsPatients from the 18F-flurpiridaz phase III clinical trial (n=498, 72% male, median age 63) who underwent PET/CT MPI and ICA within 6-months were included. TPD was quantified automatically, and CAC scores were assessed by AI and manual methods. Adding CAC score to TPD improved AUC for manual (0.87) and AI-based (0.88) scoring versus TPD alone (0.84). ConclusionsCombining TPD and CAC score enhances 18F-flurpiridaz PET MPI accuracy for CAD detection O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=110 SRC="FIGDIR/small/25330013v1_ufig1.gif" ALT="Figure 1"> View larger version (37K): [email protected]@ba93d1org.highwire.dtl.DTLVardef@13eabd9org.highwire.dtl.DTLVardef@1845505_HPS_FORMAT_FIGEXP M_FIG O_FLOATNOGraphical Abstract.C_FLOATNO Overview of the study design. C_FIG

Recent work has revisited the infamous task Name that dataset and established that in non-medical datasets, there is an underlying bias and achieved high Accuracies on the dataset origin task. In this work, we revisit the same task applied to popular open-source chest X-ray datasets. Medical images are naturally more difficult to release for open-source due to their sensitive nature, which has led to certain open-source datasets being extremely popular for research purposes. By performing the same task, we wish to explore whether dataset bias also exists in these datasets. % We deliberately try to increase the difficulty of the task by dataset transformations. We apply simple transformations of the datasets to try to identify bias. Given the importance of AI applications in medical imaging, it's vital to establish whether modern methods are taking shortcuts or are focused on the relevant pathology. We implement a range of different network architectures on the datasets: NIH, CheXpert, MIMIC-CXR and PadChest. We hope this work will encourage more explainable research being performed in medical imaging and the creation of more open-source datasets in the medical domain. The corresponding code will be released upon acceptance.

Accurate prediction of recurrence in clear cell renal cell carcinoma (ccRCC) remains a major clinical challenge due to the disease complex molecular, pathological, and clinical heterogeneity. Traditional prognostic models, which rely on single data modalities such as radiology, histopathology, or genomics, often fail to capture the full spectrum of disease complexity, resulting in suboptimal predictive accuracy. This study aims to overcome these limitations by proposing a deep learning (DL) framework that integrates multimodal data, including CT, MRI, histopathology whole slide images (WSI), clinical data, and genomic profiles, to improve the prediction of ccRCC recurrence and enhance clinical decision-making. The proposed framework utilizes a comprehensive dataset curated from multiple publicly available sources, including TCGA, TCIA, and CPTAC. To process the diverse modalities, domain-specific models are employed: CLAM, a ResNet50-based model, is used for histopathology WSIs, while MeD-3D, a pre-trained 3D-ResNet18 model, processes CT and MRI images. For structured clinical and genomic data, a multi-layer perceptron (MLP) is used. These models are designed to extract deep feature embeddings from each modality, which are then fused through an early and late integration architecture. This fusion strategy enables the model to combine complementary information from multiple sources. Additionally, the framework is designed to handle incomplete data, a common challenge in clinical settings, by enabling inference even when certain modalities are missing.

Background: Accurate forecasting of lung tumor motion is essential for precise dose delivery in proton therapy. While current markerless methods mostly rely on deep learning, transformer-based architectures remain unexplored in this domain, despite their proven performance in trajectory forecasting. Purpose: This work introduces a markerless forecasting approach for lung tumor motion using Vision Transformers (ViT). Two training strategies are evaluated under clinically realistic constraints: a patient-specific (PS) approach that learns individualized motion patterns, and a multi-patient (MP) model designed for generalization. The comparison explicitly accounts for the limited number of images that can be generated between planning and treatment sessions. Methods: Digitally reconstructed radiographs (DRRs) derived from planning 4DCT scans of 31 patients were used to train the MP model; a 32nd patient was held out for evaluation. PS models were trained using only the target patient's planning data. Both models used 16 DRRs per input and predicted tumor motion over a 1-second horizon. Performance was assessed using Average Displacement Error (ADE) and Final Displacement Error (FDE), on both planning (T1) and treatment (T2) data. Results: On T1 data, PS models outperformed MP models across all training set sizes, especially with larger datasets (up to 25,000 DRRs, p < 0.05). However, MP models demonstrated stronger robustness to inter-fractional anatomical variability and achieved comparable performance on T2 data without retraining. Conclusions: This is the first study to apply ViT architectures to markerless tumor motion forecasting. While PS models achieve higher precision, MP models offer robust out-of-the-box performance, well-suited for time-constrained clinical settings.

The development of robust deep learning models for breast ultrasound (BUS) image analysis is significantly constrained by the scarcity of expert-annotated data. To address this limitation, we propose a clinically controllable generative framework for synthesizing BUS images. This framework integrates clinical descriptions with structural masks to generate tumors, enabling fine-grained control over tumor characteristics such as morphology, echogencity, and shape. Furthermore, we design a semantic-curvature mask generator, which synthesizes structurally diverse tumor masks guided by clinical priors. During inference, synthetic tumor masks serve as input to the generative framework, producing highly personalized synthetic BUS images with tumors that reflect real-world morphological diversity. Quantitative evaluations on six public BUS datasets demonstrate the significant clinical utility of our synthetic images, showing their effectiveness in enhancing downstream breast cancer diagnosis tasks. Furthermore, visual Turing tests conducted by experienced sonographers confirm the realism of the generated images, indicating the framework's potential to support broader clinical applications.

Compressive imaging (CI) reconstruction, such as snapshot compressive imaging (SCI) and compressive sensing magnetic resonance imaging (MRI), aims to recover high-dimensional images from low-dimensional compressed measurements. This process critically relies on learning an accurate representation of the underlying high-dimensional image. However, existing unsupervised representations may struggle to achieve a desired balance between representation ability and efficiency. To overcome this limitation, we propose Tensor Decomposed multi-resolution Grid encoding (GridTD), an unsupervised continuous representation framework for CI reconstruction. GridTD optimizes a lightweight neural network and the input tensor decomposition model whose parameters are learned via multi-resolution hash grid encoding. It inherently enjoys the hierarchical modeling ability of multi-resolution grid encoding and the compactness of tensor decomposition, enabling effective and efficient reconstruction of high-dimensional images. Theoretical analyses for the algorithm's Lipschitz property, generalization error bound, and fixed-point convergence reveal the intrinsic superiority of GridTD as compared with existing continuous representation models. Extensive experiments across diverse CI tasks, including video SCI, spectral SCI, and compressive dynamic MRI reconstruction, consistently demonstrate the superiority of GridTD over existing methods, positioning GridTD as a versatile and state-of-the-art CI reconstruction method.